Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer

by Nicholas A. Pease, Trisha Wise-Draper, Lisa Privette Vinnedge
Published 2015-01-01

IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models.

by Anjelika Gasilina, Gurdat Premnauth, Purujit Gurjar, Jacek Biesiada, Shailaja Hegde, David Milewski, Gang Ma, Tanya V Kalin, Edward Merino, Jarek Meller, William Seibel, José A Cancelas, Lisa Privette Vinnedge, Nicolas N Nassar
Published 2020-01-01

Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma

by Trisha Wise-Draper, Arun Sendilnathan, Sarah Palackdharry, Nicholas Pease, Julianne Qualtieri, Randall Butler, Nooshin Hashemi Sadraei, John C. Morris, Yash Patil, Keith Wilson, Jonathan Mark, Keith Casper, Vinita Takiar, Adam Lane, Lisa Privette Vinnedge
Published 2018-02-01

Defective transcription elongation in a subset of cancers confers immunotherapy resistance

by Vishnu Modur, Navneet Singh, Vakul Mohanty, Eunah Chung, Belal Muhammad, Kwangmin Choi, Xiaoting Chen, Kashish Chetal, Nancy Ratner, Nathan Salomonis, Matthew T. Weirauch, Susan Waltz, Gang Huang, Lisa Privette-Vinnedge, Joo-Seop Park, Edith M. Janssen, Kakajan Komurov
Published 2018-10-01